German generic manufacturer in Berlin-Reinickendorf, part of the Aristo Pharma Group, producing over 1.5 billion tablets and capsules a year such as proton pump inhibitors, statins and antidepressants; Aristo announced the site's closure in 2026.
댓글이 없습니다.
평가 & 댓글 남기기